This finding is consistent with prior reports showing that the BCL-2/BCL-XL inhibitor ABT-737 leads to caspase 8 cleavage measured by western blot in AML cell lines as soon as 1 hour post-exposure (53). The gene discussed is BCL2; the disease is acute myeloid leukemia.